152 related articles for article (PubMed ID: 22018642)
41. Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study.
Williams B; Lacy PS; Cruickshank JK; Collier D; Hughes AD; Stanton A; Thom S; Thurston H;
Circulation; 2009 Jan; 119(1):53-61. PubMed ID: 19103995
[TBL] [Abstract][Full Text] [Related]
42. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study.
Stone PH; Lloyd-Jones DM; Kinlay S; Frei B; Carlson W; Rubenstein J; Andrews TC; Johnstone M; Sopko G; Cole H; Orav J; Selwyn AP; Creager MA;
Circulation; 2005 Apr; 111(14):1747-55. PubMed ID: 15809368
[TBL] [Abstract][Full Text] [Related]
43. Heterogeneous vascular responses to hypoxic forearm exercise in young and older adults.
Limberg JK; Evans TD; Pegelow DF; Eldridge MW; Sebranek JJ; Proctor LT; Schrage WG
Eur J Appl Physiol; 2012 Aug; 112(8):3087-95. PubMed ID: 22198326
[TBL] [Abstract][Full Text] [Related]
44. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting.
Ji Q; Mei Y; Wang X; Sun Y; Feng J; Cai J; Xie S; Chi L
Circ J; 2009 Dec; 73(12):2244-9. PubMed ID: 19822977
[TBL] [Abstract][Full Text] [Related]
45. Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia.
Maki KC; Bays HE; Dicklin MR; Johnson SL; Shabbout M
J Clin Lipidol; 2011; 5(6):483-92. PubMed ID: 22108152
[TBL] [Abstract][Full Text] [Related]
46. Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively.
Hunninghake D; Insull W; Toth P; Davidson D; Donovan JM; Burke SK
Atherosclerosis; 2001 Oct; 158(2):407-16. PubMed ID: 11583720
[TBL] [Abstract][Full Text] [Related]
47. Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial.
Bone HG; Kiel DP; Lindsay RS; Lewiecki EM; Bolognese MA; Leary ET; Lowe W; McClung MR
J Clin Endocrinol Metab; 2007 Dec; 92(12):4671-7. PubMed ID: 17726081
[TBL] [Abstract][Full Text] [Related]
48. Chronic endurance exercise training offsets the age-related attenuation in contraction-induced rapid vasodilation.
Hughes WE; Ueda K; Casey DP
J Appl Physiol (1985); 2016 Jun; 120(11):1335-42. PubMed ID: 27032899
[TBL] [Abstract][Full Text] [Related]
49. Effects of atorvastatin on reactive hyperaemia and the thrombosis-fibrinolysis system in patients with heart failure.
Tousoulis D; Antoniades C; Bosinakou E; Kotsopoulou M; Tsioufis C; Tentolouris C; Trikas A; Pitsavos C; Stefanadis C
Heart; 2005 Jan; 91(1):27-31. PubMed ID: 15604328
[TBL] [Abstract][Full Text] [Related]
50. The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
Soedamah-Muthu SS; Colhoun HM; Thomason MJ; Betteridge DJ; Durrington PN; Hitman GA; Fuller JH; Julier K; Mackness MI; Neil HA;
Atherosclerosis; 2003 Apr; 167(2):243-55. PubMed ID: 12818407
[TBL] [Abstract][Full Text] [Related]
51. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
Dogra GK; Watts GF; Chan DC; Stanton K
Diabet Med; 2005 Mar; 22(3):239-42. PubMed ID: 15717868
[TBL] [Abstract][Full Text] [Related]
52. A 6 month randomized, double blind, placebo controlled, multi-center trial of high dose atorvastatin on myocardial perfusion abnormalities by positron emission tomography in coronary artery disease.
Sdringola S; Gould KL; Zamarka LG; McLain R; Garner J
Am Heart J; 2008 Feb; 155(2):245-53. PubMed ID: 18215593
[TBL] [Abstract][Full Text] [Related]
53. STAR VaS--Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo-controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery.
Neilipovitz DT; Bryson GL; Taljaard M
Can J Anaesth; 2012 Jun; 59(6):527-37. PubMed ID: 22528165
[TBL] [Abstract][Full Text] [Related]
54. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.
Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Liapis CD
J Vasc Surg; 2010 Jan; 51(1):114-21. PubMed ID: 19837545
[TBL] [Abstract][Full Text] [Related]
55. Elevated extracellular potassium prior to muscle contraction reduces onset and steady-state exercise hyperemia in humans.
Terwoord JD; Hearon CM; Luckasen GJ; Richards JC; Joyner MJ; Dinenno FA
J Appl Physiol (1985); 2018 Aug; 125(2):615-623. PubMed ID: 29722620
[TBL] [Abstract][Full Text] [Related]
56. Lipid lowering efficacy of atorvastatin.
Adams SP; Tsang M; Wright JM
Cochrane Database Syst Rev; 2012 Dec; 12():CD008226. PubMed ID: 23235655
[TBL] [Abstract][Full Text] [Related]
57. Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial.
Hovingh GK; Kastelein JJ; van Deventer SJ; Round P; Ford J; Saleheen D; Rader DJ; Brewer HB; Barter PJ
Lancet; 2015 Aug; 386(9992):452-60. PubMed ID: 26047975
[TBL] [Abstract][Full Text] [Related]
58. Effect of atorvastatin on endothelium-dependent vasodilation in patients with coronary artery disease.
Vita JA; Gokce N; Duffy SJ; Kahn D; Tomasian D; Palmisano J; Thomas S; Holbrook M; Keaney JF
Am J Cardiol; 2003 Apr; 91(7):857-60. PubMed ID: 12667571
[No Abstract] [Full Text] [Related]
59. Effect of atorvastatin on ocular blood flow velocities in patients with diabetic retinopathy.
Ozkiris A; Erkiliç K; Koç A; Mistik S
Br J Ophthalmol; 2007 Jan; 91(1):69-73. PubMed ID: 16973667
[TBL] [Abstract][Full Text] [Related]
60. High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial.
Ganesan A; Crum-Cianflone N; Higgins J; Qin J; Rehm C; Metcalf J; Brandt C; Vita J; Decker CF; Sklar P; Bavaro M; Tasker S; Follmann D; Maldarelli F
J Infect Dis; 2011 Mar; 203(6):756-64. PubMed ID: 21325137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
